There were four companies in a city associated with Bossier Parish, Louisiana, that received four FDA inspections in the third quarter of 2025, according to the U.S. Food and Drug Administration (FDA).
This is a 100% increase over the number of companies inspected in the previous quarter, when two companies received two inspections.
Most of the companies inspected at the time operate in the Biologics sector. Both the Devices and Drugs sectors sectors tied for second most common type.
All of the companies were in line with FDA regulations, and don’t need to adjust their managing operations or regulatory/administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| ARK-LA-TEX Fertility and Reproductive Medicine, PMC | Biologics | 08/29/2025 | No Action Indicated (NAI) |
| KEDPlasma, LLC | Biologics | 08/28/2025 | No Action Indicated (NAI) |
| LifeShare Blood Center | Biologics | 08/21/2025 | No Action Indicated (NAI) |
| Louisiana State University Health Sciences Center-Shreveport IRB | Biologics | 07/18/2025 | No Action Indicated (NAI) |
| Louisiana State University Health Sciences Center-Shreveport IRB | Devices | 07/18/2025 | No Action Indicated (NAI) |
| Louisiana State University Health Sciences Center-Shreveport IRB | Drugs | 07/18/2025 | No Action Indicated (NAI) |
Information in this story was obtained from the U.S. Food and Drug Administration. The source data can be found here.
